Development of medical termination of pregnancy: a review

@article{Ho2017DevelopmentOM,
  title={Development of medical termination of pregnancy: a review},
  author={P. Ho},
  journal={BJOG: An International Journal of Obstetrics & Gynaecology},
  year={2017},
  volume={124},
  pages={1942 - 1947}
}
  • P. Ho
  • Published 2017
  • Medicine
  • BJOG: An International Journal of Obstetrics & Gynaecology
  • The synthesis of mifepristone, an antiprogestin blocking the action of progesterone at the receptor level, started a new era of medical termination of pregnancy (MTOP). The initial results of MTOP with mifepristone alone were disappointing; however, mifepristone can sensitise the myometrium to the action of prostaglandins. Clinical trials have shown that the sequential administration of mifepristone followed 1–2 days later by a prostaglandin analogue is a safe, effective, and acceptable method… CONTINUE READING

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 48 REFERENCES